To view or add a comment, sign in FDA Approval Update The FDA has approved Sarclisa Escena (isatuximab-irfc) from Sanofi as a subcutaneous formulation of isatuximab for approved multiple myeloma treatment combinations
Obesity, Diabetes, Weight Loss, Snacking, Binge Eating Prescriptions, Skin Rejuvenation Experience the power of Customized Dermatology Treatment to address a range of skin concerns and achieve your desired complexion
Overarching Principle The fundamental principle of regulation of medicines is to optimise timely access to effective treatments while reducing the risk of harm from improper use
Its a conservative, reasonable default
Human controlled trial data is still absent, so confidence is low
Delivered in cycles, its designed to support biological age, sleep, and skin quality while integrating lifestyle and skincare upgrades